Natasa Zamurovic Ribrioux

Natasa Zamurovic Ribrioux

Company: Novartis

Job title: Strategy & Portfolio Director-Preclinical Safety/ Translational Medicine


Understanding preclinical species selection to accurately assess pharmacology and safety of targeted protein degraders

For more information on this session, please download the full event guide.

Day: Pre-Conference Workshop Day

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.